Efficacy and safety of fentanyl inhalant for the treatment of breakthrough cancer pain: a multicenter, randomized, double-blind, placebo-controlled trial-Reference-Cited by-同舟云学术

Efficacy and safety of fentanyl inhalant for the treatment of breakthrough cancer pain: a multicenter, randomized, double-blind, placebo-controlled trial

Published:2024-09-07 Issue:1 Volume:23 Page:
ISSN:1472-684X
Container-title:BMC Palliative Care
language:en
Short-container-title:BMC Palliat Care

Author:

Lin Rongbo,Song Binbin,Li Na,Rong Biaoxue,Bai Jinghui,Liu Yong,Wang Wei,Liu Anwen,Luo Suxia,Liu Bo,Cheng Peng,Wu Yani,Li Yujie,Yu Xiaohui,Liu Xueying,Dai Xiangrong,Li Xiaoyi,Liu Dongying,Wang Jian,Huang Yan

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1186/s12904-024-01554-9.pdf

Reference26 articles.

1. Fallon M, Giusti R, Aielli F, et al. Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines. Ann Oncol. 2018;29(Supplement_4):iv166–91.

2. Deandrea S, Corli O, Consonni D, et al. Prevalence of breakthrough cancer pain: a systematic review and a pooled analysis of published literature. J Pain Symptom Manage. 2014;47(1):57–76.

3. Camps Herrero C, Batista N, Díaz Fernández N, et al. Breakthrough cancer pain: review and calls to action to improve its management. Clin Transl Oncol. 2020;22:1216–26.

4. Cuomo A, Cascella M, Forte CA, et al. Careful breakthrough cancer pain treatment through rapid-onset transmucosal fentanyl improves the quality of life in cancer patients: results from the BEST multicenter study. J Clin Med. 2020;9(4):1003.

5. Tagami K, Okizaki A, Miura T, et al. Breakthrough cancer pain influences general activities and pain management: a comparison of patients with and without breakthrough cancer pain. J Palliat Med. 2018;21(11):1636–40.